![Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study | The BMJ Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study | The BMJ](https://www.bmj.com/content/bmj/341/bmj.c4521/F3.large.jpg)
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study | The BMJ
![ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide](https://www.urotoday.com/images/figure3.png)
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
![Early Detection: Digital Rectal Exam & PSA Test Prostate Cancer Screening | Roswell Park Comprehensive Cancer Center Early Detection: Digital Rectal Exam & PSA Test Prostate Cancer Screening | Roswell Park Comprehensive Cancer Center](https://www.roswellpark.org/sites/default/files/styles/max_325x325/public/digital_rectal_exam_nci.jpg?itok=H7SAw7IF)
Early Detection: Digital Rectal Exam & PSA Test Prostate Cancer Screening | Roswell Park Comprehensive Cancer Center
![ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide](https://www.urotoday.com/images/study_attrition.png)
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
![Medical Science Monitor | Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models - Article abstract #929913 Medical Science Monitor | Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models - Article abstract #929913](https://jours.isi-science.com/imageXml.php?i=medscimonit-27-e929913-g001.jpg&idArt=929913&w=1000)
Medical Science Monitor | Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models - Article abstract #929913
![Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study | British Journal of Cancer Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-02027-7/MediaObjects/41416_2022_2027_Fig1_HTML.png)
Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study | British Journal of Cancer
![Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine - ScienceDirect Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220310702-ga1.jpg)
Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine - ScienceDirect
![Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age - European Urology Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/adcf243e-97bb-46a0-9550-4d8053985b87/gr1_lrg.jpg)
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age - European Urology
![Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708521005811-ga1.jpg)
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
![Prostate Cancer Screening Recommendations for General and Specific Populations in the Western Nations - European Medical Journal Prostate Cancer Screening Recommendations for General and Specific Populations in the Western Nations - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/11/42-940x563.jpg)
Prostate Cancer Screening Recommendations for General and Specific Populations in the Western Nations - European Medical Journal
![ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide](https://www.urotoday.com/images/ASCO_study_design1.png)
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
![Cureus | A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range? Cureus | A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?](https://assets.cureus.com/uploads/figure/file/88961/lightbox_b4cef9a013ab11ea9d7105f12cb40dc3-figure.png)
Cureus | A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
![Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong - Clinical Genitourinary Cancer Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7f169b2a-34a7-4831-b8ab-a0de51805847/gr1.jpg)
Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong - Clinical Genitourinary Cancer
![Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research](https://www.ahajournals.org/cms/asset/8fd2b1c2-75c3-4f46-bb35-e6654e9e2cc3/1492fig02.gif)